Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis
Top Cited Papers
- 1 January 2018
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Imaging
- Vol. 11 (1), e007030
- https://doi.org/10.1161/CIRCIMAGING.117.007030
Abstract
Background-Although cardiac magnetic resonance (CMR) and positron emission tomography (PET) detect different pathological attributes of cardiac sarcoidosis (CS), the complementary value of these tests has not been evaluated. Our objective was to determine the value of combining CMR and PET in assessing the likelihood of CS and guiding patient management. Methods and Results-In this retrospective study, we included 107 consecutive patients referred for evaluation of CS by both CMR and PET. Two experienced readers blinded to all clinical data reviewed CMR and PET images and categorized the likelihood of CS as no (90%) based on predefined criteria. Patient management after imaging was assessed for all patients and across categories of increasing CS likelihood. A final clinical diagnosis for each patient was assigned based on a subsequent review of all available imaging, clinical, and pathological data. Among 107 patients (age, 55 +/- 11 years; left ventricular ejection fraction, 43 +/- 16%), 91 (85%) had late gadolinium enhancement, whereas 82 (76%) had abnormal F18-fluorodeoxyglucose uptake on PET, suggesting active inflammation. Among the 91 patients with positive late gadolinium enhancement, 60 (66%) had abnormal F18-fluorodeoxyglucose uptake. When PET data were added to CMR, 48 (45%) patients were reclassified as having a higher or lower likelihood of CS, most of them (80%) being correctly reclassified when compared with the final diagnosis. Changes in immunosuppressive therapies were significantly more likely among patients with highly probable CS. Conclusions-Among patients with suspected CS, combining CMR and PET provides complementary value for estimating the likelihood of CS and guiding patient management.Keywords
This publication has 39 references indexed in Scilit:
- CMR Imaging Predicts Death and Other Adverse Events in Suspected Cardiac SarcoidosisJACC: Cardiovascular Imaging, 2013
- Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac SarcoidosisJournal of Cardiovascular Electrophysiology, 2012
- Variable Cardiac 18FDG Patterns Seen in Oncologic Positron Emission Tomography Computed TomographyJournal of Thoracic Imaging, 2012
- Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillatorsHeart Rhythm, 2012
- Detection of Myocardial Damage in Patients With SarcoidosisCirculation, 2009
- Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PETJournal of Nuclear Cardiology, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- MRI of Cardiac Sarcoidosis: Basal and Subepicardial Localization of Myocardial Lesions and Their Effect on Left Ventricular FunctionAmerican Journal of Roentgenology, 2008
- ACC/AHA/HRS 2006 Key Data Elements and Definitions for Electrophysiological Studies and Procedures: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology)Journal of the American College of Cardiology, 2006
- Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis†European Heart Journal, 2005